Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
26.74
+2.48 (10.22%)
At close: Jun 26, 2026, 4:00 PM EDT
26.69
-0.05 (-0.19%)
After-hours: Jun 26, 2026, 6:57 PM EDT
Assembly Biosciences Employees
Assembly Biosciences had 73 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
73
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$973,932
Profits / Employee
-$87,438
Market Cap
529.91M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| REGENXBIO | 371 |
| Arvinas | 246 |
| ProKidney | 231 |
| Kyverna Therapeutics | 129 |
| Rezolute | 68 |
| Prothena Corporation | 67 |
| Altimmune | 57 |
| Contineum Therapeutics | 51 |
ASMB News
- 12 days ago - Assembly Biosciences price target raised to $45 from $40 at Mizuho - TheFly
- 19 days ago - Assembly Biosciences Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 23 days ago - Assembly Biosciences Transcript: AGM 2026 - Transcripts
- 24 days ago - Assembly Biosciences Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 4 weeks ago - Assembly Biosciences Announces Upcoming Investor Conference Presentations - GlobeNewsWire
- 4 weeks ago - Assembly Biosciences Announces the Closing of its Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 5 weeks ago - Assembly Biosciences announces expansion of ABI-6250 clinical development - TheFly
- 5 weeks ago - Assembly Biosciences Announces Pricing of $100 Million Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire